deltatrials
Recruiting OBSERVATIONAL NCT06203106

NYSCF Scientific Discovery Biobank

Sponsor: New York Stem Cell Foundation Research Institute

Conditions ALS Alzheimer Disease Alzheimer Disease, Early Onset Alzheimer Disease, Late Onset Amyotrophic Lateral Sclerosis Batten Disease Cervical Cancer Corticobasal Degeneration Dementia Diabetes Diabetes Mellitus Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Frontotemporal Dementia Huntington Disease INAD Lewy Body Disease Macular Degeneration Multiple Sclerosis Multiple System Atrophy Ovarian Cancer PTSD Parkinson Disease Parkinson's Disease and Parkinsonism Post Traumatic Stress Disorder Progressive Supranuclear Palsy Uterine Cancer Vaginal Cancer Vulvar Cancer
Interventions Biological Sample Collection
Updated 5 times since 2024 Last updated: Feb 27, 2025 Started: Nov 10, 2022 Primary completion: Nov 10, 2045 Completion: Nov 10, 2045
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates ALS and Alzheimer Disease and is currently actively recruiting participants. New York Stem Cell Foundation Research Institute leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Feb 2024 – ~Apr 2024 · 2 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotRecruiting~Apr 2025 – present · 16 months · monthly snapshotRecruiting

Change History

5 versions recorded

  1. Apr 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — Apr 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Apr 2024 — Jul 2024 [monthly]

    Recruiting

  5. Feb 2024 — Apr 2024 [monthly]

    Recruiting

    First recorded

Nov 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • New York Stem Cell Foundation Research Institute
Data source: New York Stem Cell Foundation Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations